Health News Releases

  • Today December 21
March 16, 2017 13:55
Bioventus to Invest in New Clinical Research for EXOGEN®
Bioventus, a global leader in orthobiologics, today announced it will commission an innovative series of real-world evidence, direct-to-patient studies to further validate the ability of its EXOGEN Ul
March 15, 2017 14:00
First Fibroblast Injection Performed in SpinalCyte’s Landmark Trial for Spinal Disc Regeneration
SpinalCyte, LLC, a Texas-based tissue engineering technology company focused on the regrowth of the spinal disc nucleus using human dermal fibroblasts, announced the first injection of fibroblasts for
March 06, 2017 11:25
New Study by Morinaga Milk, Using Cutting Edge Technology, Confirms Age-Related Changes in Human Gut Microbiota
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading dairy product company in Japan, today announced the results of a new study that show how gut microbiota composition in a healthy human populati
March 06, 2017 09:35
Oral OTEZLA® (Apremilast) Demonstrated Significant Improvement versus Placebo in Trial of Patients with Moderate Plaque Psoriasis Who Were Naïve to Systemic and Biologic Therapy
Celgene Corporation (NASDAQ:CELG) today announced that results from its phase 4 UNVEIL trial evaluating OTEZLA® (apremilast), the Company‘s oral, selective inhibitor of phosphodiesterase 4 (PDE4), in
March 06, 2017 09:20
Celgene to Present New Data from Clinical Trials on Oral OTEZLA® (apremilast) at American Academy of Dermatology Congress
Celgene Corporation (NASDAQ:CELG) today announced that findings from ongoing clinical trials of OTEZLA® (apremilast), the Company's oral, selective inhibitor of phosphodiesterase 4 (PDE4), conducted i
March 03, 2017 09:40
Boehringer Ingelheim expands collaboration with Vanderbilt University to tackle some of the most difficult-to-treat cancers
Boehringer Ingelheim announced today a new collaboration with Vanderbilt University, Nashville, Tennessee. The multi-year program complements an already existing collaboration by focusing on the resea
March 02, 2017 16:55
Octapharma Group Publishes 2016 Annual Results Reporting Revenue of €1.6 Billion and Operating Income of €383 Million
The Octapharma Group can report a record-breaking result with sales of €1.6 billion, which represents an increase of €87 million or 5.8% compared with 2015. Octapharma achieved sales growth of 18.8
February 28, 2017 18:55
New Study Assesses the Utility of Masimo PVi® Monitoring During Colorectal Surgery
Masimo (NASDAQ: MASI) announced today the findings of a recent study conducted on low-risk patients undergoing colorectal surgery, in which researchers assessed the utility of noninvasive and continuo
February 27, 2017 09:45
REVLIMID® (Lenalidomide) Approved by the European Commission as Monotherapy for the Maintenance Treatment of Patients with Newly Diagnosed Multiple Myeloma after Autologous Stem Cell Transplantation
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that the European Commission (EC) has approved REVLIMID® (lenalidomide) as monotherapy for
February 17, 2017 14:00
World’s First Medically-Accurate Health Monitoring System Integrated in a Smartphone Now Readied For FDA Approval By Leman Micro Devices
Leman Micro Devices (LMD), the developer of accredited consumer healthcare products that is backed by major players within the mobile device industry, has announced that its Health Sensor & App - the
February 17, 2017 10:35
US FDA Expands Approval of Tiotropium Respimat® for Maintenance Treatment of Asthma in Children
Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) approved tiotropium Respimat® (marketed as SPIRIVA® Respimat®) for the long-term, once-daily maintenance treatment
February 17, 2017 09:55
Takeda Completes Acquisition of ARIAD Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) today announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) (“ARIAD”) for $24.00 per share in cash. “W
February 16, 2017 14:00
Masimo Announces CE Marking of Respiration Rate Measurement on MightySat™ Rx
Masimo (NASDAQ: MASI) announced today the CE marking of the measurement of respiration rate from the pleth (RRpTM) on the MightySat™ Rx fingertip pulse oximeter. MightySat Rx is a noninvasive device t
February 16, 2017 11:28
Boehringer Ingelheim and Weill Cornell Medicine announce new collaboration to discover next generation COPD treatments
Boehringer Ingelheim today announced a collaboration with Weill Cornell Medicine to identify new treatment approaches for chronic obstructive pulmonary disease (COPD) in order to develop novel treatme
February 15, 2017 13:50
25 Hospitals in Mexico Make a Commitment to Eliminate Preventable Death
Dr. Javier Dávila Torres, along with 11 officials from Mexico announced at the Patient Safety Movement Foundation’s (PSMF) World Patient Safety, Science & Technology Summit that 25 hospitals signed a
February 14, 2017 11:30
WIN 2017 Symposium, Expediting Global Innovation in Precision Cancer Medicine
WIN 2017 Symposium will be held in Paris, France from June 26-27, 2017. The CME accredited WIN2017 is an exceptional scientific event dedicated to “Expediting Global Innovation in Precision Cancer Med
February 13, 2017 17:30
Ferring and Foresee Pharmaceuticals Enter into Exclusive Development and Option Agreement
Ferring Pharmaceuticals and Foresee Pharmaceuticals Co., Ltd. (6576.TWO), announced today that the companies have entered into an exclusive worldwide development and option agreement to leverage Fores
February 13, 2017 10:25
Replicor Discloses Updated REP 401 Clinical Data at APASL 2017
Replicor Inc., a privately held biopharmaceutical company targeting a cure for chronic hepatitis B and D patients, today announced that an updated interim analysis from its latest REP 401 clinical tri
February 13, 2017 09:50
Renowned South Korean Pop Singer Hwang Chi-yeul Performs in Taiwan
Renowned South Korean pop singer-songwriter Hwang Chi-yeul will soon perform a live concert in Taiwan held by biotech company, Bioworld Nature, as part of the company’s “Thank-you event,” the event or
February 10, 2017 10:40
Afatinib to be evaluated in combination with PD-1 inhibitor pembrolizumab in new trial for patients with squamous cell carcinoma of the lung
Boehringer Ingelheim today announced the initiation of a Phase II trial of afatinib* (Giotrif®) in combination with pembrolizumab (Keytruda®) for patients with locally advanced or metastatic squamous
February 06, 2017 13:55
Patient Safety Movement Announces Innovation Award Winners at 5th Annual Summit
At the 5th Annual World Patient Safety, Science & Technology Summit, the winners of this year’s Innovation Awards were announced. The annual summit convened hundreds of medical professionals, hospital
February 06, 2017 10:25
Patient Safety Movement Announces 69,519 Lives Saved
The Patient Safety Movement Foundation (PSMF) announced today, at the 5th Annual Patient Safety, Science & Technology Summit, that 69,519 lives were saved in 2016, thanks to the efforts of more than 3
February 03, 2017 11:25
CellProthera Raises 8.3 Million Euros
CellProthera, a biotech company which offers the most advanced cell therapy for regeneration of the damaged heart muscle after myocardial infarction, announces it has raised €8,300,000 from private in
February 03, 2017 10:10
Celgene Receives Positive CHMP Opinion to Expand REVLIMID® (Lenalidomide) Indication as Monotherapy for the Maintenance Treatment of Patients with Newly Diagnosed Multiple Myeloma (MM) after Autologous Stem Cell Transplantation
Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ:CELG), today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (C
February 02, 2017 14:00
Masimo Announces the Addition of Early Warning Score to the Root® Patient Monitoring and Connectivity Platform
Masimo (NASDAQ: MASI) announced today the limited market release of Early Warning Score (EWS) on the Root® patient monitoring and connectivity platform. EWS aggregates information from multiple vital
25 per page50 per page75 per page100 per page